300942.SZ
易瑞生物
SZSE · Healthcare · C 制造业 · CN
CNY 6.98
+3.87%Margins
Gross margin
64.4%
EBITDA margin
13.3%
EBIT margin
-0.9%
Net margin
2.5%
FCF margin
-2.9%
0.8%
Return on equity
0.5%
Return on assets
-0.2%
Return on invested capital
0.18x
Asset turnover
CNY 55.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026